Filing Details
- Accession Number:
- 0001615219-16-000124
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-15 16:31:05
- Reporting Period:
- 2016-03-11
- Filing Date:
- 2016-03-15
- Accepted Time:
- 2016-03-15 16:31:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1615219 | Flex Pharma Inc. | FLKS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456055 | Thomas Wessel | C/O Flex Pharma, Inc. 800 Boylston Street Boston MA 02199 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-11 | 12,000 | $7.15 | 49,064 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-14 | 8,000 | $9.13 | 57,064 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $6.91 to $7.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $7.69 to $9.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Billionaire Hedge Funds
